Perrigo (PRGO -0.3%) has received FDA approval to market polacrilex, its OTC mini nicotine...
Wednesday, October 10, 2012, 12:09 PM ETPerrigo (PRGO -0.3%) has received FDA approval to market polacrilex, its OTC mini nicotine lozenges. The mint flavored mini lozenge will be marketed under retailer and wholesalers'store, or own brand labels, and is comparable to GlaxoSmithKline's (GSK -0.3%) Nicorette Mini Lozenge. PRGO says is lozenge is the first product approved that will target the individual store brand market.
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles